View in EDS

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Authors: Tremoulet AH; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA. Electronic address: atremoulet@ucsd.edu., Jain S; Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, USA., Jaggi P; Pediatrics, Nationwide Children's Hospital and Ohio State University, Columbus, OH, USA., Jimenez-Fernandez S; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA., Pancheri JM; Rady Children's Hospital San Diego, San Diego, CA, USA., Sun X; Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, USA., Kanegaye JT; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA., Kovalchin JP; Pediatrics, Nationwide Children's Hospital and Ohio State University, Columbus, OH, USA., Printz BF; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA., Ramilo O; Pediatrics, Nationwide Children's Hospital and Ohio State University, Columbus, OH, USA., Burns JC; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA.
Source: Lancet (London, England) [Lancet] 2014 May 17; Vol. 383 (9930), pp. 1731-8. Date of Electronic Publication: 2014 Feb 24.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24572997
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tremoulet+AH%22">Tremoulet AH</searchLink>; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA. Electronic address: atremoulet@ucsd.edu.<br /><searchLink fieldCode="AU" term="%22Jain+S%22">Jain S</searchLink>; Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Jaggi+P%22">Jaggi P</searchLink>; Pediatrics, Nationwide Children's Hospital and Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Jimenez-Fernandez+S%22">Jimenez-Fernandez S</searchLink>; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pancheri+JM%22">Pancheri JM</searchLink>; Rady Children's Hospital San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sun+X%22">Sun X</searchLink>; Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kanegaye+JT%22">Kanegaye JT</searchLink>; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kovalchin+JP%22">Kovalchin JP</searchLink>; Pediatrics, Nationwide Children's Hospital and Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Printz+BF%22">Printz BF</searchLink>; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ramilo+O%22">Ramilo O</searchLink>; Pediatrics, Nationwide Children's Hospital and Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Burns+JC%22">Burns JC</searchLink>; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Rady Children's Hospital San Diego, San Diego, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2014 May 17; Vol. 383 (9930), pp. 1731-8. <i>Date of Electronic Publication: </i>2014 Feb 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24572997
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(13)62298-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1731
    Titles:
      – TitleFull: Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tremoulet AH
      – PersonEntity:
          Name:
            NameFull: Jain S
      – PersonEntity:
          Name:
            NameFull: Jaggi P
      – PersonEntity:
          Name:
            NameFull: Jimenez-Fernandez S
      – PersonEntity:
          Name:
            NameFull: Pancheri JM
      – PersonEntity:
          Name:
            NameFull: Sun X
      – PersonEntity:
          Name:
            NameFull: Kanegaye JT
      – PersonEntity:
          Name:
            NameFull: Kovalchin JP
      – PersonEntity:
          Name:
            NameFull: Printz BF
      – PersonEntity:
          Name:
            NameFull: Ramilo O
      – PersonEntity:
          Name:
            NameFull: Burns JC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 05
              Text: 2014 May 17
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1474-547X
          Numbering:
            – Type: volume
              Value: 383
            – Type: issue
              Value: 9930
          Titles:
            – TitleFull: Lancet (London, England)
              Type: main
ResultId 1